The treatment recommendation for CL group focuses on compiling and updating best evidence-based, species-specific treatment recommendations for cutaneous leishmaniasis.

The Diagnostic Procedure Group evaluates and validates diagnostic methods with the aim to harmonize diagnostic procedures and methods across the network.

The biobanking group takes care of collecting, storing, and managing biological samples for research purposes within the network.

The topical paromomycin for CL treatment group focuses on the development and implementation of a planned prospective study to evaluate topical paromomycin treatment for cutaneous leishmaniasis within the network.

Group members:

• Cléa Melenotte (Group leader)
• Lorenzo Zammarchi (Group leader)
• Stefania Varani
• Jean-Pierre Gangneux
• Johan van Griensven
• Anna Checkley
• Anna Barbiero
• Bianca Granozzi
• Javier Moreno
• Eugenia Carrillo
• Begoña Monge-Maillo
• Pieter van Thiel